Carmen Muñoz Almagro
Jefe de Grupo Senior
Research group
Professional network profiles
Related websites
Last Publications
- Agüera M, Soler-García a, Alejandre C, Moussalam-Merino S, Sala-Castellví P, Pons G, Penela-Sánchez D, González-Grado C, Alsina-Rosell J, Climent C, Esteva-Afonso C, Fortuny-Guasch C, Fernández de Sevilla-Estrach M, García-García JJ, Brotons-de los Reyes P, Balaguer A, Estrada J, Jordán-García I, Munoz-Almagro C and Launes-Montana C Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study PEDIATRIC ALLERGY AND IMMUNOLOGY . 35(6): .
- Launes-Montana C, Camacho J, Marina Pons Espinal, López-Labrador FX, Esteva-Afonso C, Cabrerizo M, Fernández-García MD, Fogeda M, Masa-Calles J, López-Perea N, Echevarría JE, Munoz-Almagro C and Tarragó D Hybrid capture shotgun sequencing detected unexpected viruses in the cerebrospinal fluid of children with acute meningitis and encephalitis EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 43(5): 863-873.
- Merdrignac L, Aït El Belghiti F, Pandolfi E, Acosta L, Fabiánová K, Habington A, García Cenoz M, Bøås H, Toubiana J, Tozzi AE, Jordán-García I, Zavadilová J, O'Sullivan N, Navascués A, Flem E, Croci I, Jané M, Krížová P, Cotter S, Fernandino L, Bekkevold T, Munoz-Almagro C, Bacci S, Kramarz P, Kissling E and Savulescu C Effectiveness of one and two doses of acellular pertussis vaccines against laboratory-confirmed pertussis requiring hospitalisation in infants: Results of the PERTINENT sentinel surveillance system in six EU/EEA countries, December 2015 - December 2019. Vaccine . 42(9): 2370-2379.
Projects
- Project name:
- Estudio de la capacidad de resilencia a largo y corto plazo de la microbiota nasofaríngea y su implicación en el paso de la colonización a enfermedad invasiva por bacterias patobiontes
- Leader
- Carmen Muñoz Almagro
- Funding entities:
- Muñoz Almagro, Carmen, Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
- Code
- PI23/00049
- Starting - finishing date:
- 2024 - 2026
- Project name:
- Subvenció per a la incorporació de personal de suport als grups de recerca, corresponent als anys 2023-2025
- Leader
- Carmen Muñoz Almagro
- Funding entities:
- Generalitat de Catalunya
- Code
- SLT028/23/000262
- Starting - finishing date:
- 2023 - 2025
- Project name:
- Epidemiología molecular de profagos de neumococo y su potencial impacto en el desarrollo de enfermedad invasiva neumocócica en niños.
- Leader
- Carmen Muñoz Almagro
- Funding entities:
- Societat Catalana de Malalties Infeccioses i Microbiologia
- Code
- PCP00362
- Starting - finishing date:
- 2023 - 2024
News
-
Carmen Muñoz-Almagro has been honored by the Barcelona Medical Association for her career in biomedical research
Dr. Carmen Muñoz-Almagro, a researcher from the Institut de Recerca Sant Joan de Déu, has been honored with one of the Professional Excellence Awards, which are annually bestowed by the Barcelona Medical Association.
-
New insights into COVID-19 protection in children have revealed the presence of sACE2 in the saliva
The presence of the soluble angiotensin-converting enzyme 2 (sACE2) in saliva could have implications for COVID-19 infection, prevention and control, according to researchers from the Institut de Recerca Sant Joan de Déu and the University of Catalunya. This study has been published in Scientific Reports.
-
Relationship of environmental exposure to nitrogen oxide with the severity of rhinovirus infection
Researchers at Institut de Recerca Sant Joan de Déu (IRSJD) · SJD Barcelona Children's Hospital have found that exposure to higher concentrations of atmospheric nitrogen oxide in childhood is associated with greater severity of rhinovirus infection and a higher number of admissions to the Paediatric Intensive Care Unit.
More activities
-
Defensa tesi doctoral: Daniel Penela Sánchez
Auditori Plaza, Hospital Sant Joan de Déu · Online